Free Cash Flow - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ryvu Therapeutics SA
Free Cash Flow Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Free Cash Flow
-zł283m
CAGR 3-Years
-96%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Free Cash Flow
-zł948k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
9%
M
Medicofarma Biotech SA
WSE:MDB
Free Cash Flow
-zł1.1m
CAGR 3-Years
-53%
CAGR 5-Years
-123%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Free Cash Flow
zł34.2m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Free Cash Flow?
Free Cash Flow
-283m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Free Cash Flow amounts to -283m PLN.

What is Ryvu Therapeutics SA's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-27%

Over the last year, the Free Cash Flow growth was -2 265%. The average annual Free Cash Flow growth rates for Ryvu Therapeutics SA have been -96% over the past three years , -27% over the past five years .

Back to Top